We are live on ! Find out more
Victory Capital Management

Victory Capital Management Portfolio holdings

AUM $178B
1-Year Est. Return 37.23%
This Fund
S&P 500
This Quarter Est. Return
+5.82%
1 Year Est. Return
+37.23%
3 Year Est. Return
+100.22%
5 Year Est. Return
+128.39%
10 Year Est. Return
+575.99%
AUM
$48.5B
AUM Growth
+$1.47B
Cap. Flow
-$1.53B
Cap. Flow %
-3.15%
Top 10 Hldgs %
6.63%
Holding
1,973
New
160
Increased
850
Reduced
654
Closed
189

Sector Composition

Rank Sector Weight
1 Financials 17.89%
2 Industrials 14.53%
3 Technology 14.21%
4 Consumer Discretionary 11.69%
5 Healthcare 10.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RARE icon
1701
Ultragenyx Pharmaceutical
RARE
$2.55B
$39K ﹤0.01%
510
+67
+15% +$5.45K
DEI icon
1702
Douglas Emmett
DEI
$1.96B
$38K ﹤0.01%
1,005
TPC
1703
Tutor Perini Cor
TPC
$5.21B
$37K ﹤0.01%
1,982
-11,912
-86% -$231K
CDNA icon
1704
CareDx
CDNA
$2.42B
$35K ﹤0.01%
+1,202
New +$22.5K
DCPH
1705
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$33K ﹤0.01%
843
+111
+15% +$4.1K
ATNX
1706
DELISTED
Athenex, Inc. Common Stock
ATNX
$31K ﹤0.01%
+99
New +$34.8K
CBLK
1707
DELISTED
Carbon Black, Inc. Common Stock
CBLK
$29K ﹤0.01%
1,376
+181
+15% +$4.25K
STML
1708
DELISTED
Stemline Therapeutics, Inc.
STML
$27K ﹤0.01%
1,609
+211
+15% +$3.38K
RIGL icon
1709
Rigel Pharmaceuticals
RIGL
$750M
$26K ﹤0.01%
812
+107
+15% +$3.21K
TTSH
1710
DELISTED
Tile Shop Holdings
TTSH
$26K ﹤0.01%
3,670
+483
+15% +$3.85K
SGYP
1711
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
$26K ﹤0.01%
15,551
+2,044
+15% +$3.66K
SGB
1712
DELISTED
Southwest Georgia Financial Corporation
SGB
$26K ﹤0.01%
+1,125
New +$25.6K
NWS icon
1713
News Corp Class B
NWS
$17.5B
$25K ﹤0.01%
1,837
-5
-0.3% -$72
TUSK icon
1714
Mammoth Energy Services
TUSK
$163M
$24K ﹤0.01%
816
XLK icon
1715
State Street Technology Select Sector SPDR ETF
XLK
$124B
$24K ﹤0.01%
+638
New +$23.4K
FOMX
1716
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
$24K ﹤0.01%
4,125
+542
+15% +$3.1K
CSTE icon
1717
Caesarstone
CSTE
$79.5M
$23K ﹤0.01%
1,252
+165
+15% +$2.9K
ZLAB icon
1718
Zai Lab
ZLAB
$2.62B
$23K ﹤0.01%
1,172
+154
+15% +$3.34K
CLLS
1719
Cellectis
CLLS
$285M
$22K ﹤0.01%
786
+103
+15% +$2.96K
DVAX
1720
DELISTED
Dynavax Technologies
DVAX
$22K ﹤0.01%
1,792
+235
+15% +$3.18K
COLL icon
1721
Collegium Pharmaceutical
COLL
$956M
$21K ﹤0.01%
1,413
+186
+15% +$3.3K
MDXG icon
1722
MiMedx Group
MDXG
$633M
$21K ﹤0.01%
3,432
-13,909
-80% -$62.9K
XLP icon
1723
State Street Consumer Staples Select Sector SPDR ETF
XLP
$14.9B
$20K ﹤0.01%
379
LXRX icon
1724
Lexicon Pharmaceuticals
LXRX
$1.1B
$19K ﹤0.01%
1,792
-80,015
-98% -$917K
MTZ icon
1725
MasTec
MTZ
$21.9B
$19K ﹤0.01%
418

Similar funds

Victory Capital Management's Q3 2018 Portfolio in Review

As of Q3 2018, Victory Capital Management held 1,973 positions worth $48.5B, up 3.1% from $47B the previous quarter. Its ten largest holdings account for 6.6% of the portfolio.

Victory Capital Management withdrew a net $1.53B in Q3 2018, closing 189 positions and reducing 654 holdings. Its most notable exit was Validus Hold Ltd, an estimated $110M position sold in full.

By sector, the portfolio is most concentrated in Financials at 18% of assets, down from 18% a quarter earlier, followed by Industrials and Technology.

Against the trend, Victory Capital Management opened a new position in Healthcare Realty worth $180M.

  • Victory Capital Management's largest Q3 2018 buy was Healthcare Realty: 6,766,300 shares worth $180M.
  • Victory Capital Management added most to Carter's in Q3 2018, an estimated $228M increase.
  • Victory Capital Management's biggest Q3 2018 reduction was Energen, cutting an estimated $193M.
  • Victory Capital Management fully exited Validus Hold Ltd in Q3 2018, selling an estimated $110M.
  • Victory Capital Management's ten largest holdings make up 6.6% of its $48.5B portfolio in Q3 2018.
  • Victory Capital Management opened 160 new positions and closed 189 in Q3 2018.
  • Victory Capital Management's portfolio value rose 3.1% quarter-over-quarter to $48.5B.

Based on Victory Capital Management's 13F filing for Q3 2018, filed 1 Nov 2018.